'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Rosacea to Dermatology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Rosacea Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Rosacea 30
Sep 28, 2016: Dermata Therapeutics, LLC Announces Positive Top-line Results from their Phase 1 Pharmacokinetic Study of DMT210 in Acne Rosacea Patients 30
Sep 12, 2016: Foamix Announces Positive Topline Results from Phase 2 Trial Evaluating FMX-103 Topical Minocycline Foam for Moderate-to-Severe Papulopustular Rosacea 30
Clinical Trial Profile Snapshots 32
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 108
List of Tables
Rosacea Therapeutics, Global, Clinical Trials by Region, 2016* 6
Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Rosacea Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Rosacea Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2016* 14
Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2016* 17
Rosacea Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Rosacea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Rosacea Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
List of Figures
Rosacea Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Rosacea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Rosacea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Rosacea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Rosacea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Rosacea Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Rosacea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Rosacea to Dermatology Clinical Trials, G7 Countries (%), 2016* 14
Rosacea Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Rosacea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Rosacea to Dermatology Clinical Trials, E7 Countries (%), 2016* 17
Rosacea Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Rosacea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Rosacea Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Rosacea Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Rosacea Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Rosacea Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Rosacea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Rosacea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Rosacea Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Rosacea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Rosacea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 106